Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy.
Location: PAMF (Peninsula/South Bay/Santa Cruz)
Please contact: Renee Kaneshiro at kaneshr@pamf.org about Artios
Principal Investigator
Ariele L Greenfield, M.D., Director of PAMF Multiple Sclerosis Center, Minal Bhanushali, MD, PAMFRI Medical Director
Related Studies
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA